Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment

Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment

Bibliographic Details
Main Authors:	Federico Angriman, Maria Nelly Gutierrez Acevedo, Maria Sol Rossi, Alberto Daniel Gimenez Conca, Victoria Otero, Jorge Alberto Arbelbide, Hernán Michelángelo
Format:	Article
Language:	English
Published:	Galenos Publishing House 2015-05-01
Series:	Turkish Journal of Hematology
Subjects:	acute promyelocytic leukemia all-trans retinoic acid bcr/abl pml/rar-α imatinib
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-90187

Similar Items

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
by: Shuang Fu, et al.
Published: (2023-06-01)

The significance of low PU.1 expression in patients with acute promyelocytic leukemia
by: Zhu Xuehua, et al.
Published: (2012-05-01)

DISTRIBUTION OF DIFFERENT PML/RARΑ BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
by: Tathagata Chatterjee, et al.
Published: (2013-12-01)

Clinical analysis of 82 cases of acute promyelocytic leukemia with PML-RARα short isoform in children and adults
by: Qiaolin Huang, et al.
Published: (2024-02-01)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia
by: Mariam Fatima, et al.
Published: (2021-06-01)

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
by: Anna Kreutzman, et al.
Published: (2019-09-01)

Distinct Characteristics of Sweet’s Syndrome of the Scrotum Caused by All-trans Retinoic Acid in a Patient with Acute Promyelocytic Leukemia
by: Osamu Imataki, et al.
Published: (2021-10-01)

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
by: Xuejing Shao, et al.
Published: (2022-04-01)

Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
by: Rachid Lahlil, et al.
Published: (2023-11-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

3 ISOFORMS OF PML RARA IN ACUTE PROMYELOCYTIC LEUKAEMIA
by: Memoona Khan, et al.
Published: (2018-12-01)

Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13,20)- A case report with a literature review
by: Siyu Gu, et al.
Published: (2021-04-01)

Distribution of different bcr isoforms and hematological profile in Indian APML patients
by: Tathagata Chatterjee, et al.
Published: (2014-08-01)

Mutations Associated with Imatinib Mesylate Resistance - Review
by: Linev Alexandar J., et al.
Published: (2018-12-01)

Nilotinib efficacy in a patient resistant to imatinib
by: Luigia Luciano
Published: (2015-10-01)

Complete molecular response induced by nilotinib in a patient previously treated with imatinib, nilotinib and dasatinib
by: Giuseppe Pietrantuono
Published: (2015-10-01)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
by: Abhilash Chandra, et al.
Published: (2020-04-01)

History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies
by: Pierre Bercier, et al.
Published: (2024-03-01)

Nilotinib early switch efficacy in non-optimal responder CML patient after first line imatinib treatment
by: Ferdinando Porretto
Published: (2015-10-01)

Influence of late treatment on how chronic myeloid leukemia responds to imatinib
by: Ana Carolina Costa Scerni, et al.
Published: (2009-01-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
by: Liuya Wei, et al.
Published: (2020-09-01)

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA
by: Buket Altinok Gunes, et al.
Published: (2023-01-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia
by: Bui Thi Kim Ly, et al.
Published: (2017-08-01)

Deeper and Early Molecular Response is a Good Predictor for Risk of Relapse in Patients with Acute Promyelocytic Leukemia
by: Chun-Kai Liao, et al.
Published: (2015-06-01)

A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells
by: Patricia Martín-Rodríguez, et al.
Published: (2019-01-01)

Clinical characteristics of a patient with de novo acute promyelocytic leukemia with JAK2 v617f mutation
by: Yi-zhi Jiang, et al.
Published: (2022-12-01)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
by: Dachuan Zeng, et al.
Published: (2022-05-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia
by: Xavier Thomas
Published: (2019-02-01)

Acute promyelocytic leukemia presenting with atypical basophils
by: Afshin Shameli, et al.
Published: (2020-03-01)

O MESILATO DE IMATINIBE COMO TRATAMENTO PARA INIBIR A PROLIFERAÇÃO DAS CÉLULAS NEOPLÁSICAS EM PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA.
by: Matias Nunes Frizzo, et al.
Published: (2016-08-01)

Monitoração molecular da Leucemia Mielóide Crônica na era do imatinibe Molecular monitoring of Chronic Myeloid Leukemia in the imatinib era
by: Israel Bendit
Published: (2008-04-01)

First report of acute promyelocytic leukemia in a patient with Wilson’s disease: contemporary discussion of a management challenge
by: Zainab AlDawood, et al.
Published: (2023-12-01)

Extending the duration of response in chronic myelogenous leukemia: targeted therapy with sequential tyrosine kinase inhibitors
by: Michael G. Martin, et al.
Published: (2011-12-01)

Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway
by: Xuefei Wang, et al.
Published: (2019-04-01)

De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome
by: Min Xiao, et al.
Published: (2011-11-01)